PMC full text:
Published online 2012 Feb 24. doi: 10.1093/brain/aws004
Table 6
Feature | C9ORF72 | MAPT | PGRN |
---|---|---|---|
Demographic | |||
Sex | Male = Female | Male = Female | Male = Female |
Age at onset, median (range) (years) | 52 (33–72) | 45 (25–65) | 59 (35–85) |
Survival, median (range) (years) | 5 (1–17) | 7 (2–25) | 6 (3–15) |
Inheritance | |||
Inheritance pattern | Autosomal dominant | Autosomal dominant | Autosomal dominant |
Frequency of sporadic cases | ++ | + | + |
Penetrance | Probably high | Almost 100% | 90% by age 70 |
Anticipation suggested | ++ | 0 | + |
Clinical | |||
Behavioural variant FTD phenotype | ++++ | ++++ | +++ |
ALS phenotype | ++++ | + | + |
FTD/ALS phenotype | +++ | + | + |
Parkinsonism | ++ | +++ | ++ |
PPA/corticobasal syndrome phenotypea | 0 | + | ++ |
Alzheimer-like phenotypea | + | + | + |
Neuropsychological | |||
Impaired psychomotor speed | ++++ | ++++ | ++++ |
Impaired complex attention/executive functioning | ++++ | ++++ | ++++ |
Impaired word retrieval | ++++ | +++ | +++ |
Impaired episodic memory | ++ | ++ | ++ |
Impaired gross visuospatial functioning | + | + | + |
Impaired confrontation naming | + | +++ | ++ |
Impaired word reading | 0 | + | + |
MRI | |||
Dorsolateral frontal/insular atrophy | +++ | ++ | ++ |
Parietal cortex atrophy | ++ | + | ++ |
Temporal cortex atrophy | + | +++ | ++ |
Markedly focal or asymmetric atrophy | 0 | + | +++ |
White matter signal changes | 0 | + | ++ |
SPECT/PET | |||
Dorsomedial frontal/cingulate abnormal | +++ | ++ | ++ |
Parietal cortex abnormal | ++ | + | ++ |
Temporal cortex abnormal | + | +++ | ++ |
Markedly focal or asymmetric findings | 0 | + | +++ |
Subcortical structures abnormal | 0 | + | + |
Neuropathology | |||
Key proteinopathy | TDP-43 | tau | TDP-43 |
TDP-43 type pathology | A and B | Not applicable | A only |
0 = not present;+ =infrequent;++ occurred with some frequency; +++ moderately frequent; ++++ very frequent.
a Since only probands with the behavioural variant FTD, non-fluent/agrammatic and semantic subtypes of primary progressive aphasia (PPA), and ALS were screened for the GGGGCC expansion, the frequency of primary progressive aphasia, corticobasal syndrome, autosomal dominant, and other phenotypes with this mutation may be higher than suggested here. Yet among those probands screened, and their affected relatives, the frequencies of these syndromes were low.